Quale sarebbe il prezzo per Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Il prezzo per Lushang Freda Pharmaceutical Co.,Ltd. (600223) è $0.83325484

Qual è la capitalizzazione di mercato per Lushang Freda Pharmaceutical Co.,Ltd. (600223)

La capitalizzazione di mercato per Lushang Freda Pharmaceutical Co.,Ltd. (600223) è $847.06M

Ricavi di Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.

Anno	Ricavi	Cambia
Non abbastanza dati per le date fornite.

Anno

Ricavi

Cambia

Non abbastanza dati per le date fornite.

Azienda	Ricavi	Differenza nei ricavi	Il paese
Sun Hung Kai Properties Limited 0016.HK	$11.88B	-	HK
China Resources Land Limited 1109.HK	$40.22B	-	HK
Emaar Properties PJSC EMAAR.AE	-	-	AE
CK Asset Holdings Limited 1113.HK	$9.53B	-	HK
Sumitomo Realty & Development Co., Ltd. 8830.T	$6.82B	-	JP

Azienda

Ricavi

Differenza nei ricavi

Il paese